Zynerba Pharma (ZYNE) Reports Q4 Loss of $0.33/sh

Zynerba Pharma (NASDAQ: ZYNE) reported Q4 EPS of ($0.33), versus ($0.46) reported last year.

For earnings history and earnings-related data on Zynerba Pharma (ZYNE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners